📊 MRSH Key Takeaways
Is MRSH a Good Investment? Thesis Analysis
Marsh & McLennan demonstrates strong fundamental business quality with robust profitability margins (23.1% operating, 15.4% net) and exceptional returns on equity (27.2%), supported by solid revenue growth of 10.3% YoY. The company generates substantial free cash flow of $5.0B annually with an 18.5% FCF margin, providing financial flexibility despite elevated leverage, while strong interest coverage of 39.1x indicates manageable debt servicing.
Why Buy MRSH? Key Strengths
- Exceptional profitability with 15.4% net margin and 27.2% ROE, demonstrating efficient capital deployment
- Strong cash generation with $5.0B free cash flow (18.5% FCF margin) providing financial flexibility
- Solid revenue growth of 10.3% YoY combined with stable operating leverage at 23.1% operating margin
- Fortress balance sheet quality evidenced by 39.1x interest coverage ratio despite 1.28x debt-to-equity
MRSH Investment Risks to Consider
- Elevated financial leverage at 1.28x debt-to-equity with $19.6B long-term debt requiring management focus on deleveraging
- Tight liquidity position with current ratio of 1.10x leaves limited margin for operational disruptions
- Net income declined 1.7% YoY despite 10.3% revenue growth, suggesting margin compression or operational challenges that warrant investigation
Key Metrics to Watch
- Operating margin trend and sustainability given net income compression despite revenue growth
- Debt-to-equity ratio trajectory and cash flow allocation toward deleveraging versus capital returns
- Free cash flow conversion and capital expenditure intensity as percentage of revenue
MRSH Financial Metrics
💡 AI Analyst Insight
MARSH & MCLENNAN COMPANIES, INC. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
MRSH Profitability Ratios
MRSH vs Finance Sector
How MARSH & MCLENNAN COMPANIES, INC. compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is MRSH Overvalued or Undervalued?
Based on fundamental analysis, MARSH & MCLENNAN COMPANIES, INC. has mixed fundamental signals relative to the Finance sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
MRSH Balance Sheet & Liquidity
MRSH 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: MARSH & MCLENNAN COMPANIES, INC.'s revenue has grown significantly by 10% over the 5-year period, indicating strong business expansion. The most recent EPS of $7.53 reflects profitable operations.
MRSH Growth Metrics (YoY)
MRSH Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $5.7B | $747.0M | $1.51 |
| Q2 2025 | $6.2B | $1.1B | $2.27 |
| Q1 2025 | $6.5B | $1.4B | $2.79 |
| Q3 2024 | $5.4B | $730.0M | $1.47 |
| Q2 2024 | $5.9B | $1.0B | $2.07 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
MRSH Capital Allocation
MRSH SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for MARSH & MCLENNAN COMPANIES, INC. (CIK: 0000062709)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MRSH
What is the AI rating for MRSH?
MARSH & MCLENNAN COMPANIES, INC. (MRSH) has an AI rating of BUY with 82% confidence, based on fundamental analysis of SEC EDGAR filings.
What are MRSH's key strengths?
Claude: Exceptional profitability with 15.4% net margin and 27.2% ROE, demonstrating efficient capital deployment. Strong cash generation with $5.0B free cash flow (18.5% FCF margin) providing financial flexibility.
What are the risks of investing in MRSH?
Claude: Elevated financial leverage at 1.28x debt-to-equity with $19.6B long-term debt requiring management focus on deleveraging. Tight liquidity position with current ratio of 1.10x leaves limited margin for operational disruptions.
What is MRSH's revenue and growth?
MARSH & MCLENNAN COMPANIES, INC. reported revenue of $27.0B.
Does MRSH pay dividends?
MARSH & MCLENNAN COMPANIES, INC. pays dividends, with $1,699.0M distributed to shareholders in the trailing twelve months.
Where can I find MRSH SEC filings?
Official SEC filings for MARSH & MCLENNAN COMPANIES, INC. (CIK: 0000062709) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MRSH's EPS?
MARSH & MCLENNAN COMPANIES, INC. has a diluted EPS of $8.43.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MRSH a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, MARSH & MCLENNAN COMPANIES, INC. has a BUY rating with 82% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is MRSH stock overvalued or undervalued?
Valuation metrics for MRSH: ROE of 27.2% (sector avg: 12%), net margin of 15.4% (sector avg: 25%). Higher ROE suggests strong returns relative to peers.
Should I buy MRSH stock in 2026?
Our dual AI analysis gives MARSH & MCLENNAN COMPANIES, INC. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MRSH's free cash flow?
MARSH & MCLENNAN COMPANIES, INC.'s operating cash flow is $5.3B, with capital expenditures of $291.0M. FCF margin is 18.5%.
How does MRSH compare to other Finance stocks?
Vs Finance sector averages: Net margin 15.4% (avg: 25%), ROE 27.2% (avg: 12%), current ratio 1.10 (avg: 1.2).